(Q33919337)

30 July 2017

1 reference

title

Lung cancer and positron emission tomography with fluorodeoxyglucose (English)

1 reference

positron emission tomography

30 July 2017

1 reference

1 reference

Marom EM

1

1 reference

PubMed ID

10812188

30 July 2017

Erasmus JJ

series ordinal

2

1 reference

PubMed ID

10812188

30 July 2017

Patz EF

series ordinal

3

1 reference

30 July 2017

1 June 2000

1 reference

30 July 2017

1 reference

30 July 2017

28

1 reference

30 July 2017

3

1 reference

30 July 2017

187-202

1 reference

Enzymology of cancer cells (first of two parts).

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Insulin, growth factors, and cancer cell energy metabolism: an hypothesis on oncogene action

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Growth factors, mitogens, oncogenes and the regulation of glucose transport

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Over-expression of facilitative glucose transporter genes in human cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Glucose utilization in vivo by human pulmonary neoplasms.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

The solitary circumscribed pulmonary nodule; study of seven hundred five cases encountered roentgenologically in a period of three and one-half years

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Lung nodule enhancement at CT: prospective findings

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Differentiating benign from malignant lung lesions using "quantitative" parameters of FDG PET images

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

PET and [18F]-FDG in oncology: a clinical update

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose. The Members of the PET-Lung Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Prospective investigation of positron emission tomography in lung nodules

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Preoperative staging of non-small-cell carcinoma of the lung: imaging methods

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Analytical decision model for the cost-effective management of solitary pulmonary nodules.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Detection of extrathoracic metastases by positron emission tomography in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Staging non-small cell lung cancer with whole-body PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Primary lung cancer staging: prospective comparative study of MR imaging with CT

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Mediastinal nodes in bronchogenic carcinoma: comparison between CT and mediastinoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Prospective evaluation of computed tomography and mediastinoscopy in mediastinal lymph node staging

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Staging non-small cell lung cancer by whole-body positron emission tomographic imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Cost-effectiveness of PET imaging in clinical oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Distribution of distant metastases from newly diagnosed non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Clinical staging of patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Isolated adrenal masses in nonsmall-cell bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Computed tomography and the TNM classification of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Preoperative CT evaluation of adrenal glands in non-small cell bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Non-small cell lung carcinoma adrenal metastases. Computed tomography and percutaneous needle biopsy in their diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Incidence and significance of serendipitous CT findings in the oncologic patient

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Extrathoracic staging of bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Analysis of published studies on the detection of extrathoracic metastases in patients presumed to have operable non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Cerebral metastases from lung carcinoma: neurological and CT correlation. Work in progress

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Brain metastasis in resected lung cancer: value of intensive follow-up with computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Brain metastases from non-central nervous system tumors: evaluation with PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Lung cancer staging and management: comparison of contrast-enhanced and nonenhanced helical CT of the thorax

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Clinical evaluation of whole-body 18F-fluorodeoxyglucose positron emission tomography in the detection of liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Evaluation of benign vs malignant hepatic lesions with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Contribution of PET in the detection of liver metastases from pancreatic tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Follow-up in lung cancer: how often and for what purpose?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Characterization of chest masses by FDG positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Positron emission tomography for treatment evaluation and recurrence detection compared with CT in long-term follow-up cases of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Clinical assessment of therapeutic effects on cancer using 18F-2-fluoro-2-deoxy-D-glucose and positron emission tomography: preliminary study of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa-N2 non-small-cell lung cancer: a prospective pilot study. The Leuven Lung Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

PET scans approved for detecting metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Imaging of lung cancer with fluorine-18 fluorodeoxyglucose: comparison of a dual-head gamma camera in coincidence mode with a full-ring positron emission tomography system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

Can dual-headed 18F-FDG SPET imaging reliably supersede PET in clinical oncology? A comparative study in lung and gastrointestinal tract cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900096-9

7 January 2021

10.1016/S0169-5002(00)00096-9

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10812188